检索结果 - Adrian Wiestner

Refine Results
  1. 1
    Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

    Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia 由 Adrian Wiestner

    出版 2012
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia

    The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia 由 Adrian Wiestner

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

    Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia 由 Adrian Wiestner

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    B-cell receptor signaling as a driver of lymphoma development and evolution

    B-cell receptor signaling as a driver of lymphoma development and evolution 由 Carsten Utoft Niemann, Adrian Wiestner

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    TOSO, the Fcμ Receptor, Is Highly Expressed on Chronic Lymphocytic Leukemia B Cells, Internalizes upon IgM Binding, Shuttles to the Lysosome, and Is Downregulated in Response to TLR Activation

    TOSO, the Fcμ Receptor, Is Highly Expressed on Chronic Lymphocytic Leukemia B Cells, Internalizes upon IgM Binding, Shuttles to the Lysosome, and Is Downregulated in Response to TL... 由 Bérengère Vire, Alexandre David, Adrian Wiestner

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets

    Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets 由 R Stoffel, Adrian Wiestner, Skoda Rc

    出版 1996
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL

    Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL 由 Maissa Mhibik, Adrian Wiestner, Clare Sun

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

    Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era 由 Patricia Pérez‐Galán, Martin Dreyling, Adrian Wiestner

    出版 2010
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    Ibrutinib for Chronic Lymphocytic Leukemia with <i>TP53</i> Alterations

    Ibrutinib for Chronic Lymphocytic Leukemia with <i>TP53</i> Alterations 由 Inhye E. Ahn, Xin Tian, Adrian Wiestner

    出版 2020
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  10. 10
    Biology of Chronic Lymphocytic Leukemia in Different Microenvironments

    Biology of Chronic Lymphocytic Leukemia in Different Microenvironments 由 Yair Herishanu, Ben‐Zion Katz, Andrew Lipsky, Adrian Wiestner

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections

    Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections 由 Andreas F. Widmer, Adrian Wiestner, Reno Frei, W. Zimmerli

    出版 1991
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene

    Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene 由 Nico Ghilardi, Adrian Wiestner, Masahiro Kikuchi, Akimichi Ohsaka, Radek C. Skoda

    出版 1999
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Targeting malignant B cells with an immunotoxin against ROR1

    Targeting malignant B cells with an immunotoxin against ROR1 由 Sivasubramanian Baskar, Adrian Wiestner, Wyndham H. Wilson, Ira Pastan, Christoph Rader

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies

    Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies 由 Jiahui Yang, Sivasubramanian Baskar, Ka Yin Kwong, Michael G. Kennedy, Adrian Wiestner, Christoph Rader

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Defective STAT signaling by the leptin receptor in diabetic mice.

    Defective STAT signaling by the leptin receptor in diabetic mice. 由 Nico Ghilardi, Suzanne Ziegler, Adrian Wiestner, R Stoffel, Markus H. Heim, Radek C. Skoda

    出版 1996
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib

    Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib 由 Inhye E. Ahn, Theresa Jerussi, Mohammed Farooqui, Xin Tian, Adrian Wiestner, Juan Gea‐Banacloche

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

    Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib 由 Clare Sun, Jin Gao, Laura Couzens, Xin Tian, Mohammed Farooqui, Maryna C. Eichelberger, Adrian Wiestner

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

    A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma 由 George W. Wright, Bruce K. Tan, Andreas Rosenwald, Elaine H. Hurt, Adrian Wiestner, Louis M. Staudt

    出版 2003
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Treatment with Ibrutinib Inhibits BTK- and VLA-4–Dependent Adhesion of Chronic Lymphocytic Leukemia Cells <i>In Vivo</i>

    Treatment with Ibrutinib Inhibits BTK- and VLA-4–Dependent Adhesion of Chronic Lymphocytic Leukemia Cells <i>In Vivo</i> 由 Sarah E. M. Herman, Rashida Z. Mustafa, Jade Jones, Deanna H. Wong, Mohammed Farooqui, Adrian Wiestner

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia

    Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia 由 Sarah E. M. Herman, Paul M. Barr, Erin M. McAuley, Danping Liu, Adrian Wiestner, Jonathan W. Friedberg

    出版 2013
    获取全文
    Carta
    加到收藏夹
    Saved in:

检索工具: